News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
247,330 Results
Type
Article (5856)
Company Profile (21)
Press Release (241453)
Multimedia
Podcasts (1)
Webinars (5)
Section
Business (87676)
Career Advice (470)
Deals (16481)
Drug Delivery (9)
Drug Development (21237)
Employer Resources (32)
FDA (4053)
Job Trends (4550)
News (129839)
Policy (8503)
Tag
Academia (337)
Accelerated approval (2)
Adcomms (3)
Allergies (10)
Alliances (16229)
ALS (28)
Alzheimer's disease (326)
Antibody-drug conjugate (ADC) (17)
Approvals (4082)
Artificial intelligence (61)
Autoimmune disease (8)
Automation (4)
Bankruptcy (107)
Best Places to Work (3387)
Biosimilars (20)
Biotechnology (28)
Bladder cancer (16)
Brain cancer (8)
Breast cancer (85)
Cancer (637)
Cardiovascular disease (33)
Career advice (402)
Career pathing (3)
CAR-T (44)
CDC (2)
Cell therapy (126)
Cervical cancer (2)
Clinical research (17946)
Collaboration (245)
Compensation (230)
Complete response letters (3)
COVID-19 (451)
CRISPR (13)
C-suite (161)
Cystic fibrosis (19)
Data (765)
Denatured (1)
Depression (12)
Diabetes (59)
Diagnostics (2272)
Digital health (4)
Diversity, equity & inclusion (14)
Drug discovery (30)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (17)
Earnings (43363)
Editorial (2)
Employer branding (6)
Employer resources (34)
Events (40939)
Executive appointments (390)
FDA (4459)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (277)
Gene editing (22)
Generative AI (2)
Gene therapy (60)
GLP-1 (138)
Government (525)
Guidances (94)
Healthcare (5579)
Huntington's disease (3)
IgA nephropathy (8)
Immunology and inflammation (19)
Indications (9)
Infectious disease (472)
Inflammatory bowel disease (26)
Inflation Reduction Act (3)
Influenza (3)
Intellectual property (18)
Interviews (57)
IPO (8450)
IRA (3)
Job creations (1260)
Job search strategy (365)
Kidney cancer (9)
Labor market (5)
Layoffs (107)
Leadership (5)
Legal (2721)
Liver cancer (19)
Lung cancer (72)
Lymphoma (40)
Machine learning (1)
Management (11)
Manufacturing (76)
MASH (33)
Medical device (4320)
Medtech (4322)
Mergers & acquisitions (8356)
Metabolic disorders (159)
Multiple sclerosis (13)
NASH (6)
Neurodegenerative disease (16)
Neuropsychiatric disorders (2)
Neuroscience (474)
NextGen: Class of 2025 (1793)
Non-profit (793)
Now hiring (3)
Obesity (67)
Opinion (31)
Ovarian cancer (19)
Pain (20)
Pancreatic cancer (25)
Parkinson's disease (37)
Partnered (8)
Patents (38)
Patient recruitment (43)
Peanut (5)
People (26636)
Pharmaceutical (8)
Pharmacy benefit managers (2)
Phase I (5327)
Phase II (7906)
Phase III (6168)
Pipeline (803)
Policy (11)
Postmarket research (660)
Preclinical (2122)
Press Release (67)
Prostate cancer (41)
Psychedelics (5)
Radiopharmaceuticals (120)
Rare diseases (97)
Real estate (2017)
Recruiting (9)
Regulatory (5747)
Reports (18)
Research institute (353)
Resumes & cover letters (68)
Rett syndrome (8)
RNA editing (3)
Schizophrenia (32)
Series A (39)
Series B (30)
Service/supplier (2)
Sickle cell disease (8)
Special edition (1)
Spinal muscular atrophy (31)
Sponsored (5)
Startups (1126)
State (1)
Stomach cancer (1)
Supply chain (14)
Tariffs (5)
Vaccines (70)
Venture capital (4)
Weight loss (25)
Women's health (3)
Date
Today (5)
Last 7 days (128)
Last 30 days (570)
Last 365 days (10454)
2025 (5518)
2024 (12208)
2023 (14509)
2022 (20474)
2021 (21860)
2020 (19716)
2019 (14307)
2018 (11012)
2017 (10871)
2016 (10001)
2015 (13155)
2014 (10372)
2013 (8354)
2012 (9045)
2011 (9449)
2010 (9259)
Location
Africa (200)
Alabama (16)
Alaska (2)
Arizona (72)
Arkansas (1)
Asia (12273)
Australia (1691)
California (2459)
Canada (1281)
China (96)
Colorado (111)
Connecticut (110)
Delaware (49)
Europe (26203)
Florida (380)
Georgia (46)
Idaho (24)
Illinois (130)
India (7)
Indiana (96)
Iowa (7)
Japan (112)
Kansas (25)
Kentucky (14)
Louisiana (6)
Maine (43)
Maryland (262)
Massachusetts (2012)
Michigan (118)
Minnesota (166)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (14)
Nevada (35)
New Hampshire (24)
New Jersey (861)
New Mexico (8)
New York (639)
North Carolina (396)
North Dakota (4)
Northern California (1174)
Ohio (74)
Oklahoma (8)
Oregon (4)
Pennsylvania (464)
Puerto Rico (2)
Rhode Island (14)
South America (308)
South Carolina (10)
Southern California (886)
Tennessee (53)
Texas (344)
United States (9243)
Utah (73)
Virginia (61)
Washington D.C. (15)
Washington State (209)
West Virginia (2)
Wisconsin (41)
247,330 Results for "apotex corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Apotex Corp. Launches Generic Fertility Treatment Injectable Cetrorelix® in the United States
Apotex Corp. announced the launch of Cetrorelix Acetate for Injection 0.25mg, a generic version of Cetrotide® in the United States.
May 14, 2024
·
1 min read
Press Releases
Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats
July 3, 2025
·
2 min read
BioMidwest
Apotex Corp. Launches Teriparatide Injectable for Osteoporosis Treatment in the United States
Apotex Corp. announced the launch of Teriparatide Injection, a single-patient-use pre-filled pen used for the treatment of osteoporosis in the United States.
November 21, 2023
·
1 min read
Press Releases
Apotex Corp. is the first generic manufacturer to launch dasatinib tablets in the United States
September 4, 2024
·
1 min read
Press Releases
Apotex introduces IVRA™ (Melphalan) hydrochloride injection: First ready to dilute liquid formulation of Melphalan injection approved via 505(b)(2) NDA in the United States
May 9, 2025
·
1 min read
Press Releases
Apotex publishes 2024 Sustainability Report, highlighting progress and achievements in environmentally sustainable manufacturing, responsible business practices, and social impact
May 21, 2025
·
2 min read
Press Releases
Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal
February 25, 2025
·
4 min read
Apotex Corp. Launches Brimonidine Tartrate Ophthalmic Solution, 0.1% in the United States
Apotex Corp. has released its latest ophthalmic product in the United States, announcing today that brimonidine tartrate ophthalmic solution, 0.1% is now available.
September 5, 2023
·
1 min read
Press Releases
Apotex acquires US rights to PROVIGIL® (modafinil) and NUVIGIL® (armodafinil)
January 9, 2025
·
2 min read
Press Releases
Apotex announces expansion of licensing agreement with Formosa Pharmaceuticals to Mexico for commercialization of clobetasol propionate ophthalmic suspension for the treatment of inflammation and pain following ocular surgery
May 7, 2025
·
3 min read
1 of 24,733
Next
